Expressing a novel class of heavy chain antibodies
表达一类新型重链抗体
基本信息
- 批准号:10432883
- 负责人:
- 金额:$ 20.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-25 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:Amino AcidsAntibodiesAntibody RepertoireAntigensArginineBacterial AntigensBacterial CapsulesBindingBinding SitesBypassCell WallChargeChondrichthyesComplementary DNACoupledDiseaseEpitopesEventExonsFishesFutureGenesHaptensHumanImmune responseImmunoglobulinsImmunotherapyInfectionLigand BindingLigandsLightLlamaLysineMicrobeMolecularMonoclonal AntibodiesMormyridaeMouse Cell LineMutant Strains MiceProteinsReading FramesReagentReportingRoleSharkStreptococcus pneumoniaeSurfaceTestingTransgenesTransgenic MiceV(D)J RecombinationVertebratesantibody detectionantigen bindingbasedrug developmentexperimental studyflexibilitynovelpathogenpolypeptidetool
项目摘要
PROJECT SUMMARY
Heavy chain antibodies (HCAbs) are an unusual species of immunoglobulins expressed by camelids
and sharks. They occur as homodimers in which the variable (V) domain of each polypeptide binds ligand.
Without the requirement for the light chain partner in conventional antibodies, HCAb reagents have the
advantage of size and molecular manipulability and are promising tools for drug development and
immunotherapy.
Genes encoding HCAbs evolved separately in two subclasses of cartilaginous fish that diverged 420
million years ago. The role of their HCAbs and pathogen recognition capabilities have not been
characterized, although it has been determined that HCAb convex antigen-combining sites can detect
epitopes inaccessible or bypassed by conventional antibodies. We have discovered novel antibody genes in
a cartilaginous fish whose component gene segments have evolved to encode and rearrange to express
lysines and arginines at the ligand-binding sites. An antibody repertoire whose major antigen-combining
loop is flexible and electropositive is unique among vertebrates, presenting an opportunity to seek antigenic
determinants different from what has been classically defined.
Transgenic mice will be generated to express a set of chimeric fish genes. The first aim of this
proposal is to generate the mutant mice, the second is to test the ability of the transgene repertoire to
respond to various immunogens. Experiments are proposed to test for HCAb detection of novel epitopes in
bacterial capsule and cell wall. Future studies will ascertain their protectiveness against disease.
项目概要
重链抗体 (HCAb) 是骆驼科动物表达的一种不寻常的免疫球蛋白
和鲨鱼。它们以同二聚体的形式出现,其中每个多肽的可变 (V) 结构域结合配体。
HCAb 试剂不需要传统抗体中的轻链伴侣,
尺寸和分子可操作性的优势,是药物开发和药物开发的有前途的工具
免疫疗法。
第420章 编码HCAb的基因在软骨鱼的两个亚类中分别进化
万年前。它们的 HCAb 和病原体识别能力的作用尚未得到证实。
尽管已确定 HCAb 凸面抗原结合位点可以检测到
常规抗体无法接近或绕过的表位。我们发现了新的抗体基因
一种软骨鱼,其组成基因片段已进化为编码和重新排列以表达
配体结合位点上的赖氨酸和精氨酸。一种抗体库,其主要抗原结合
环是灵活的,正电性在脊椎动物中是独一无二的,提供了寻找抗原的机会
与经典定义不同的决定因素。
将产生转基因小鼠来表达一组嵌合鱼基因。本次活动的第一个目的
建议一是产生突变小鼠,二是测试转基因库的能力
对各种免疫原作出反应。建议进行实验来测试 HCAb 对新表位的检测
细菌荚膜和细胞壁。未来的研究将确定它们对疾病的保护作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELLEN HSU其他文献
ELLEN HSU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELLEN HSU', 18)}}的其他基金
Expressing a novel class of heavy chain antibodies
表达一类新型重链抗体
- 批准号:
10555257 - 财政年份:2022
- 资助金额:
$ 20.19万 - 项目类别:
Immunoglobulin Constant Region Switch and Hypermutation in the Nurse Shark
护士鲨的免疫球蛋白恒定区转换和超突变
- 批准号:
8008955 - 财政年份:2010
- 资助金额:
$ 20.19万 - 项目类别:
Isotype Exclusion and Hypermutation in the Nurse Shark
护士鲨的同种型排斥和超突变
- 批准号:
6728164 - 财政年份:2004
- 资助金额:
$ 20.19万 - 项目类别:
Isotype Exclusion and Hypermutation in the Nurse Shark
护士鲨的同种型排斥和超突变
- 批准号:
6838254 - 财政年份:2004
- 资助金额:
$ 20.19万 - 项目类别:
Immunoglobulin Constant Region Switch and Hypermutation in the Nurse Shark
护士鲨的免疫球蛋白恒定区转换和超突变
- 批准号:
8102776 - 财政年份:2004
- 资助金额:
$ 20.19万 - 项目类别:
Isotype Exclusion and Hypermutation in the Nurse Shark
护士鲨的同种型排斥和超突变
- 批准号:
7163418 - 财政年份:2004
- 资助金额:
$ 20.19万 - 项目类别:
Immunoglobulin Constant Region Switch and Hypermutation in the Nurse Shark
护士鲨的免疫球蛋白恒定区转换和超突变
- 批准号:
7736714 - 财政年份:2004
- 资助金额:
$ 20.19万 - 项目类别:
Immunoglobulin gene expression and recombinational events in the nurse shark
护士鲨的免疫球蛋白基因表达和重组事件
- 批准号:
9322603 - 财政年份:2004
- 资助金额:
$ 20.19万 - 项目类别:
Immunoglobulin Constant Region Switch and Hypermutation in the Nurse Shark
护士鲨的免疫球蛋白恒定区转换和超突变
- 批准号:
8299117 - 财政年份:2004
- 资助金额:
$ 20.19万 - 项目类别:
Immunoglobulin gene expression and recombinational events in the nurse shark
护士鲨的免疫球蛋白基因表达和重组事件
- 批准号:
9172265 - 财政年份:2004
- 资助金额:
$ 20.19万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 20.19万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 20.19万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 20.19万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 20.19万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 20.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 20.19万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 20.19万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 20.19万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 20.19万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 20.19万 - 项目类别:














{{item.name}}会员




